Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02054884
Status:
TERMINATED
Last Update Posted:
2018-05-18
First Post:
2014-01-31
Brief Title:
F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma
Sponsor:
Philogen SpA
Organization:
Philogen SpA
Organization Data
Organization:
Philogen SpA
Class:
INDUSTRY
Study ID:
PH-F16IL2TAXO-0312
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Philogen SpA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Immatics Biotechnologies GmbH | INDUSTRY |